SE7910204L - N-(fenoxialkyl)-imidazoler, som selektivt inhiberar tromboxan syntetasenzymets verkan. sett att framstella nemnda imidazolderivat. farmaceutiska beredningar vilka som huvudsaklig aktiv bestandsdel innehaller ett ... - Google Patents

N-(fenoxialkyl)-imidazoler, som selektivt inhiberar tromboxan syntetasenzymets verkan. sett att framstella nemnda imidazolderivat. farmaceutiska beredningar vilka som huvudsaklig aktiv bestandsdel innehaller ett ...

Info

Publication number
SE7910204L
SE7910204L SE7910204A SE7910204A SE7910204L SE 7910204 L SE7910204 L SE 7910204L SE 7910204 A SE7910204 A SE 7910204A SE 7910204 A SE7910204 A SE 7910204A SE 7910204 L SE7910204 L SE 7910204L
Authority
SE
Sweden
Prior art keywords
tromboxan
syntetasenzym
phenoxialkyl
imidazoles
preparing
Prior art date
Application number
SE7910204A
Other languages
English (en)
Other versions
SE444937B (sv
Inventor
P E Cross
R P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7910204(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of SE7910204L publication Critical patent/SE7910204L/sv
Publication of SE444937B publication Critical patent/SE444937B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7910204A 1978-12-13 1979-12-11 N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat SE444937B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13

Publications (2)

Publication Number Publication Date
SE7910204L true SE7910204L (sv) 1980-06-14
SE444937B SE444937B (sv) 1986-05-20

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7910204A SE444937B (sv) 1978-12-13 1979-12-11 N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat

Country Status (34)

Country Link
US (2) US4602016A (sv)
JP (1) JPS585197B2 (sv)
KR (1) KR830001243B1 (sv)
AR (1) AR227637A1 (sv)
AT (1) AT373879B (sv)
AU (1) AU517892B2 (sv)
BE (1) BE880584A (sv)
CA (1) CA1108137A (sv)
CH (1) CH644597A5 (sv)
CS (1) CS216517B2 (sv)
DD (1) DD147943A5 (sv)
DE (1) DE2950019A1 (sv)
DK (1) DK471479A (sv)
EG (1) EG14227A (sv)
ES (1) ES8101556A1 (sv)
FI (1) FI70888C (sv)
FR (1) FR2444031A1 (sv)
GB (1) GB2038821B (sv)
GR (1) GR73003B (sv)
HU (1) HU183016B (sv)
IE (1) IE49318B1 (sv)
IL (1) IL58917A (sv)
IT (1) IT1194900B (sv)
LU (1) LU81985A1 (sv)
NL (1) NL177749C (sv)
NO (1) NO153135C (sv)
NZ (1) NZ192360A (sv)
PH (1) PH15056A (sv)
PL (1) PL134005B1 (sv)
PT (1) PT70571A (sv)
SE (1) SE444937B (sv)
SU (1) SU878195A3 (sv)
YU (1) YU301879A (sv)
ZA (1) ZA796708B (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES539074A0 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
JPH0625141B2 (ja) * 1985-01-16 1994-04-06 三共株式会社 イミダゾ−ル誘導体およびその製法
NO166644C (no) 1986-01-28 1991-08-21 Sankyo Co Analogifremgangsmaate til fremstilling av tianaftenderivater.
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
DE3860908D1 (de) * 1987-04-03 1990-12-06 Cl Pharma Neue 2-thienyloxyessigsaeurederivate, ein verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
WO1999045905A2 (en) * 1998-03-13 1999-09-16 Pozen Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
US20050020657A1 (en) * 2002-07-09 2005-01-27 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2
AU2004264722A1 (en) * 2003-08-07 2005-02-24 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
AR091112A1 (es) * 2012-05-22 2015-01-14 Genentech Inc Benzamidas n-sustituidas como inhibidores de los canales de sodio nav1.7
CN104869992A (zh) 2012-10-26 2015-08-26 默沙东公司 具有电压门控性钠通道选择性活性的n-取代的吲唑磺酰胺化合物
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途
WO2023240378A1 (zh) * 2022-06-13 2023-12-21 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
PL134005B1 (en) 1985-07-31
ES486782A0 (es) 1980-12-16
IT7941669A0 (it) 1979-12-11
EG14227A (en) 1983-12-31
AU5372579A (en) 1980-06-19
US4602016A (en) 1986-07-22
KR830001242A (ko) 1983-04-29
FR2444031A1 (fr) 1980-07-11
DD147943A5 (de) 1981-04-29
AU517892B2 (en) 1981-09-03
ATA783379A (de) 1983-07-15
NL177749B (nl) 1985-06-17
US4636500A (en) 1987-01-13
IL58917A0 (en) 1980-03-31
DK471479A (da) 1980-06-14
CS216517B2 (en) 1982-11-26
NO153135C (no) 1986-01-22
FR2444031B1 (sv) 1983-06-10
GB2038821B (en) 1982-12-08
FI70888B (fi) 1986-07-18
HU183016B (en) 1984-04-28
GR73003B (sv) 1984-01-24
ES8101556A1 (es) 1980-12-16
NL7908899A (nl) 1980-06-17
IL58917A (en) 1984-03-30
SU878195A3 (ru) 1981-10-30
PL220351A1 (sv) 1980-12-01
SE444937B (sv) 1986-05-20
PH15056A (en) 1982-06-03
GB2038821A (en) 1980-07-30
NZ192360A (en) 1982-02-23
JPS585197B2 (ja) 1983-01-29
ZA796708B (en) 1981-08-26
IT1194900B (it) 1988-09-28
NO794069L (no) 1980-06-16
BE880584A (fr) 1980-06-12
DE2950019A1 (de) 1980-07-10
NO153135B (no) 1985-10-14
AR227637A1 (es) 1982-11-30
FI793868A (fi) 1980-06-14
FI70888C (fi) 1986-10-27
IE792403L (en) 1980-06-13
JPS5585572A (en) 1980-06-27
YU301879A (en) 1983-01-21
CA1108137A (en) 1981-09-01
LU81985A1 (fr) 1980-04-22
KR830001243B1 (ko) 1983-06-27
NL177749C (nl) 1985-11-18
AT373879B (de) 1984-02-27
CH644597A5 (de) 1984-08-15
PT70571A (en) 1980-01-01
IE49318B1 (en) 1985-09-18

Similar Documents

Publication Publication Date Title
SE7910204L (sv) N-(fenoxialkyl)-imidazoler, som selektivt inhiberar tromboxan syntetasenzymets verkan. sett att framstella nemnda imidazolderivat. farmaceutiska beredningar vilka som huvudsaklig aktiv bestandsdel innehaller ett ...
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO160261C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-metyl-11-aza-10-deokso-10-dihydroerytromycin a.
NL7900807A (nl) Imidazoolderivaten en zouten daarvan, alsmede hun bereiding, tussenprodukten en farmaceutische preparaten daarvan.
NL7904013A (nl) Farmaceutische verpakking.
NO891317D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive difosfat-derivater.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO910935L (no) Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater.
NL8402946A (nl) Antidepressieve 1,2,4-triazolon verbindingen; werkwijzen voor het bereiden daarvan; farmaceutische preparaten.
IT7922743A0 (it) Componente di dosaggio farmaceutico a emissione controllata.
NL187485C (nl) Prostaglandinederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat.
NL7805066A (nl) Verpakking voor radiofarmaceutische preparaten.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO167861C (no) Analogifremgangsmaate for fremstilling av en ny, terapeutisk aktiv indolokinolinforbindelse.
NO159793C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 1-(4-arylcykloheksyl)-piperidinderivat.
NL187239C (nl) N-gesubstitueerd 2-cyaanaziridinederivaat, werkwijze voor het bereiden daarvan en farmaceutisch preparaat dat een dergelijk preparaat bevat.
DK681887D0 (da) Azolderivat, fremgangsmaade til fresmtilling heraf samt landburgsmaessigt/havebrugsmaessigt fungicid indeholdende derivatet som aktiv bestanddel
DK110979A (da) 1,1-diphenylethen-derivater som mikrobicid
NO153951C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tilberedning som inneholder 8-metoksy-furo-(3[ ,2[:6,7)-cumarin.
NO158343C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(ureidocykloheksylamino)-propan-1,2-diol-derivater.
NO154493C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 1-substituerte-3-cycloalkyl-sulfonyl-pyrrolidin-2,5-dion-derivater.
NO147601C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse l-pyroglutamyl-l-histidyl-glycin
NO154840C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte 2-amino-3,4-dihydropyridinderivater.
NO145135C (no) Analogifremgangsmaate ved fremstilling av den terapeutisk aktive forbindelse 3-cyan-n-(n,n-diemtylaminopropyl)-iminodibenzyl